" class="no-js "lang="en-US"> Peter Small - Medtech Alert
Tuesday, June 17, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Peter Small

Peter Small

About Peter Small

Outcome driven leader with expertise in clinical medicine (infectious disease), applied research, product development, and innovative health care delivery and global health diplomacy. With a demonstrated history of bridging cultures to wrestle innovative ideas into impactful programs and products. Adept at situational assessment, strategic thinking, partner relations, interdisciplinary team building and management.

Related Story

Appointments

 Respiratory Monitoring Medtech Firm Appoints Global Expert Dr. Peter Small as Chief Medical Officer | Pharmtech Focus

Respiratory Monitoring Medtech Firm Appoints Global Expert Dr. Peter Small as Chief Medical Officer

September 9 2021

Fast-growing AI Medtech company Hyfe has, today, announced the appointment of world-renowned Seattle-based physician and […]